'Our Aim Is To Scout And Spot Untapped Rural Students Potentials'
Express Pharma|November 1-15, 2017

Pulsus currently focusses towards expanding healthcare informatics and pharmacovigilance market studies of the current and future prospects of the global healthcare market. Dr Srinubabu, CEO Pulsus HealthTech, reveals more in an interaction with Express Pharma

Dr Srinubabu,
'Our Aim Is To Scout And Spot Untapped Rural Students Potentials'
Can you explain the idea behind Pulsus HealthTech?

Pulsus Group is a health informatics and healthcare services company and publisher of scientific, technical, and medical literatures. It was established in 1984 primarily to publish peer-reviewed medical journals. Pulsus Group conducts conferences in association with scientific societies.

Pulsus Group is a medical and healthcare publisher since three decades and received accolades from the contributors and the readers. At present, Pulsus Group is diversifying its publishing portfolio to other realms by incorporating all major science, technology, medical journals as an ardent scientific publisher of open access and hybrid access peer reviewed journals. With a view to preserve, pursue, share and distribute scientific discoveries and knowledge, Pulsus currently focusses towards expanding healthcare informatics and pharma covigilance market studies of the current and future prospects of the global healthcare market.

Pulsus was focussing on American region and presently expanding to healthcare informatics platform to the medical and pharma professionals throughout Europe, America, Asia, Australia and all other continents. Since its inception, Pulsus received endorsements of medical associations and industries of international repute. This support allowed Pulsus Group to gain excellent reputation from the scientific and industrial community and able to bridge relations between industries and practicing physicians.

Pulsus Pharma covigilance works including collection, archival and monitoring of individual case study reports, studies with reference to four phases of clinical research and development of existing and emerging molecules, adverse drug reaction reports, effectiveness and risk factors assessment.

Bu hikaye Express Pharma dergisinin November 1-15, 2017 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye Express Pharma dergisinin November 1-15, 2017 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

EXPRESS PHARMA DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
MAKING SUSTAINABILITY SUSTAINABLE
Express Pharma

MAKING SUSTAINABILITY SUSTAINABLE

Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, MSME pharma companies need to carefully balance their sustainability goals with financial viability

time-read
10+ dak  |
September 2024
New energy recovery system for tablet coaters
Express Pharma

New energy recovery system for tablet coaters

Upto 50 per cent less steam energy consumption

time-read
5 dak  |
September 2024
The future of pharma logistics: Trends, challenges, and opportunities
Express Pharma

The future of pharma logistics: Trends, challenges, and opportunities

Nikhil Agarwal, President, CJ Darcl Logistics explains that the future of pharma logistics is a thrilling frontier shaped by technological advancements, regulatory challenges, and the imperative of sustainability. As the industry transforms, logistics providers must embrace innovative solutions and adapt to shifting demands

time-read
3 dak  |
September 2024
Achieving Aatmanirbharta In APIs Are We On The Right Track?
Express Pharma

Achieving Aatmanirbharta In APIs Are We On The Right Track?

As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats

time-read
9 dak  |
August 2021
Yokogawa launches OpreX Data Model Broker
Express Pharma

Yokogawa launches OpreX Data Model Broker

A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation

time-read
2 dak  |
August 2021
Understanding the nuances of generics injectables
Express Pharma

Understanding the nuances of generics injectables

At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial

time-read
6 dak  |
August 2021
Trending in nutraceuticals: Science meets sustainability
Express Pharma

Trending in nutraceuticals: Science meets sustainability

Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe

time-read
3 dak  |
August 2021
The growth of e-pharmacies in India
Express Pharma

The growth of e-pharmacies in India

Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these

time-read
4 dak  |
August 2021
Xylitol and Maltitol: Low-calorie sugar alternatives
Express Pharma

Xylitol and Maltitol: Low-calorie sugar alternatives

Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste

time-read
4 dak  |
August 2021
Single-use TC gaskets and their importance
Express Pharma

Single-use TC gaskets and their importance

Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.

time-read
2 dak  |
August 2021